The emerging nanomedicine landscape, Nat Biotechnol, vol.24, pp.1211-1217, 2006. ,
Polymeric micelles -a new generation of colloidal drug carriers, Eur J Pharm Biopharm, vol.48, pp.101-111, 1999. ,
Dendrimers: emerging polymers for drug-delivery systems, Eur J Pharm Sci, vol.38, pp.185-196, 2009. ,
Carbon Nanotubes: Its role in modern health care, Int J Pharm Pharm Sci, vol.5, pp.9-13, 2003. ,
Nanogels as pharmaceutical carriers: finite networks of infinite capabilities, Angew Chem Int Ed Engl, vol.48, pp.5418-5429, 2009. ,
Liposomes for brain delivery, Expert Opin Drug Deliv, vol.10, pp.1003-1022, 2013. ,
Lipid nanoparticles for cancer therapy: state of the art and future prospects, Expert Opin Drug Deliv, vol.9, pp.1245-1261, 2012. ,
Lipid nanomedicines for anticancer drug therapy, J Biomed Nanotechnol, vol.5, pp.323-343, 2009. ,
Diagnostic and therapeutic uses of nanomaterials in the brain, Curr Med Chem, vol.21, pp.4100-4131, 2014. ,
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities, Pharmacol Ther, vol.104, pp.29-45, 2004. ,
Physiology and pharmacological role of the blood-brain barrier, Pharmacol Rep, vol.60, pp.600-622, 2008. ,
Recent advances in the brain-to-blood efflux transport across the blood-brain barrier, Int J Pharm, vol.248, pp.15-29, 2002. ,
Nanotechnology-novel therapeutics for CNS disorders, Nat Rev Neurol, vol.8, pp.307-318, 2012. ,
Nanomedicine--challenge and perspectives, Angew Chem Int Ed Engl, vol.48, pp.872-897, 2009. ,
Alzheimer's disease, N Engl J Med, vol.362, pp.329-344, 2010. ,
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs, Br J Clin Pharmacol, vol.73, pp.504-517, 2012. ,
Novel L-lactide-depsipeptide polymeric carrier for enhanced brain uptake of rivastigmine in treatment of Alzheimer's disease, J Biomed Nanotechnol, vol.10, pp.415-426, 2014. ,
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting, Eur J Pharm Sci, vol.47, pp.6-15, 2012. ,
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease, Brain Res, vol.1200, pp.159-168, 2008. ,
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles, Eur J Pharm Biopharm, vol.70, pp.75-84, 2008. ,
Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine, Nanomedicine, vol.6, pp.144-152, 2010. ,
Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting, Drug Dev Ind Pharm, vol.40, pp.278-287, 2014. ,
The use of borneol as an enhancer for targeting aprotininconjugated PEG-PLGA nanoparticles to the brain, Pharm Res, vol.30, pp.2560-2572, 2013. ,
VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease, J Control Release, vol.170, pp.111-119, 2013. ,
B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide, Bioconjug Chem, vol.24, pp.997-1007, 2013. ,
Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides, Pharm Res, vol.30, pp.1813-1823, 2013. ,
Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology, J Control Release, vol.150, pp.220-228, 2011. ,
Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc?) in the neuronal cell culture and animal model: implications for Alzheimer's disease, J Alzheimers Dis, vol.23, pp.61-77, 2011. ,
Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits, J Control Release, vol.185, pp.121-129, 2014. ,
Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice, AAPS J, vol.15, pp.324-336, 2013. ,
Molecular properties of lysine dendrimers and their interactions with Aβ-peptides and neuronal cells, Curr Med Chem, vol.20, pp.134-143, 2013. ,
Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB, AAPS PharmSciTech, vol.10, pp.900-905, 2009. ,
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice, Biomaterials, vol.35, pp.456-465, 2014. ,
A review of Parkinson's disease, Br Med Bull, vol.86, pp.109-127, 2008. ,
Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems, Maturitas, vol.76, pp.272-278, 2013. ,
Current management of Parkinson's disease, Ann Afr Med, vol.9, pp.55-61, 2010. ,
Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain, Int J Pharm, vol.382, pp.277-290, 2009. ,
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery, Int J Pharm, vol.419, pp.296-307, 2011. ,
Dopamine-loaded chitosan nanoparticles: formulation and analytical characterization, Anal Bioanal Chem, vol.400, pp.1997-2002, 2011. ,
Novel surface modified polymer-lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation. See comment in PubMed Commons below, J Mater Sci Mater Med, vol.24, pp.2101-2115, 2013. ,
Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration, J Controlled Release, vol.151, pp.131-138, 2011. ,
Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease, Int J Pharm, vol.415, pp.273-283, 2011. ,
Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model, J Neurol Sci, vol.290, pp.123-130, 2010. ,
Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles, J Gene Med, vol.11, pp.754-763, 2009. ,
The use of lactoferrin as a ligand for targeting the polyamidoaminebased gene delivery system to the brain, Biomaterials, vol.29, pp.238-246, 2008. ,
Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons, Cell Transplant, vol.18, pp.1183-1196, 2009. ,
Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80, Bull Exp Biol Med, vol.145, pp.259-262, 2008. ,
Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease, Nanomedicine (Lond), vol.5, pp.379-396, 2010. ,
A macrophage-nanozyme delivery system for Parkinson's disease, Bioconjug Chem, vol.18, pp.1498-1506, 2007. ,
PAMAM dendrimers as potential agents against fibrillation of alpha-synuclein, a Parkinson's disease-related protein, Macromol Biosci, vol.9, pp.230-238, 2009. ,
PAMAM G4 dendrimers affect the aggregation of α-synuclein, Int J Biol Macromol, vol.48, pp.742-746, 2011. ,
Phosphorus-containing dendrimers against α-synuclein fibril formation, Int J Biol Macromol, vol.50, pp.1138-1143, 2012. ,
Viologen-Phosphorus Dendrimers Inhibit α-Synuclein Fibrillation, Mol Pharm, vol.10, pp.1131-1137, 2013. ,
Adrenomedullin and nitric oxide: implications for the etiology and treatment of primary brain tumors, CNS Neurol Disord Drug Targets, vol.10, pp.820-833, 2011. ,
Glioblastoma and other malignant gliomas: a clinical review, JAMA, vol.310, pp.1842-1850, 2013. ,
Nanotherapeutic approaches for brain cancer management, Nanomedicine, vol.10, pp.905-919, 2014. ,
A classification of the tumors of the glioma group on a histogenic basis with a correlated study of prognosis, J B Lippincott Co. Philadelphia. USA, 1926. ,
Malignant glioma: genetics and biology of a grave matter, Genes Dev, vol.15, pp.1311-1333, 2001. ,
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma, Proc Natl Acad Sci U S A, vol.110, pp.11751-11756, 2013. ,
Brain cancer diagnosis and therapy with nanoplatforms, Adv Drug Deliv Rev, vol.58, pp.1556-1577, 2006. ,
Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors, Biomaterials, vol.33, pp.583-591, 2012. ,
A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue, Sci Transl Med, vol.4, pp.149-119, 2012. ,
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect, J Control Release, vol.143, pp.136-142, 2010. ,
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy, Biomaterials, vol.34, pp.196-208, 2013. ,
Functional nanoparticles in targeting glioma diagnosis and therapies, J Nanosci Nanotechnol, vol.14, pp.415-432, 2014. ,
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2, J Neurochem, vol.106, pp.1534-1544, 2008. ,
Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein, Cancer Res, vol.60, pp.2300-2303, 2000. ,
Angiopep-conjugated poly(ethylene glycol)-co-poly(εcaprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma, Biomaterials, vol.32, pp.4293-4305, 2011. ,
Anti-glioblastoma efficacy and safety of paclitaxelloading Angiopep-conjugated dual targeting PEG-PCL nanoparticles, Biomaterials, vol.33, pp.8167-8176, 2012. ,
Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance, Int J Cancer, vol.127, pp.2063-2075, 2010. ,
EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma, Biomaterials, vol.35, pp.4133-4145, 2014. ,
EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery, Biomaterials, vol.31, pp.5619-5626, 2010. ,
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles, Biomaterials, vol.33, pp.5115-5123, 2012. ,
In vitro and in vivo intracellular distribution and antiglioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide, Int J Pharm, vol.466, pp.8-17, 2014. ,